Belt up your trenchcoat and grab your false-bottomed sample case: Big Pharma's spies have called a conclave, and most of them won't even have to leave New Jersey. Just what is "competitive ...

Whether happening in public or private, biopharma M&A is fiercer than ever. Experts point to patent pressures, herd mentality ...

CHAPEL HILL, N.C., Sept. 13, 2011 /PRNewswire/ -- Pharmaceutical Competitive Intelligence functions look to internal colleagues and departments to unearth critical insights. Internal groups most often ...

LONDON--(BUSINESS WIRE)--Infiniti Research is the world's leading independent provider of strategic market intelligence solutions. Our market intelligence services are designed to connect your ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Pharmaceutical and biotechnology companies have increased their competitive intelligence (CI) budgets in the U.S. by an average 62 percent over the last ...

Ferring Pharmaceuticals, a Swiss biopharma firm, focuses on worker well-being and DEI. Purvi Tailor, head of human resources in its US business, is on BI's Workforce Innovation board. This article is ...

On Monday, BridgeBio Pharma, Inc. (NASDAQ:BBIO) presented initial outcomes from the ATTRibute-CM open-label extension (OLE) study of acoramidis in ATTR-CM at the American Heart Association Scientific ...

Molekule Consulting Inc. ("Molekule") today announces its exhibiting at the 2014 Pharma Competitive Intelligence Conference & Exhibition USA – September 9-10, 2014 Parsippany, NJ. Molekule is ...

The pharmaceutical industry is engaging in a flurry of biotech deals and shifting clinical trials to China. It does so at a time when the U.S. is distancing from China.

In 2010, U.S. pharmaceutical sales grew at 2. 3%; and since 2001 market has grown at a CAGR of 6. 6%. Pharmaceutical sales in the United States are expected to reach US$328 billion in 2011 and up to ...

The OLE study involves 330 participants who completed the 30-month ATTRibute-CM Phase 3 study. Key initial results from the OLE study show that continuous treatment with acoramidis led to: The OLE ...